08-10-2018 12:27 PM CET - Health & Medicine
Print

Chronic Kidney Disease (CKD) Drugs Market Analysis 2023: Johnson & Johnson, Abbott Laboratories, F. Hoffmann-La Roche, Takeda Pharmaceuticals, Actavis, Akebia Therapeutic, Raptor Pharmaceuticals, Rockwell Medical, AMAG Pharmaceuticals, Sanofi, Reata Pharm

Press release from: Qurate Business Intelligence


Chronic Kidney Disease (CKD) Drugs market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.

The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.

Request Free Sample Report@ www.qurateresearch.com/report/sample/HnM/QBI-ICR-HnM-20027

Global Chronic Kidney Disease (CKD) Drugs Market: Product Segment Analysis
Hyperphosphatemia: Dietary phosphate binders and dietary phosphate restriction
Hypocalcemia: Calcium supplements and possibly calcitriol
Hyperparathyroidism: Calcitriol or vitamin D analogues
Anemia: Iron replacement therapy and erythropoiesis-stimulating agents

Global Chronic Kidney Disease (CKD) Drugs Market: Application Segment Analysis
Hospital use
Clinic use
Household

Global Chronic Kidney Disease (CKD) Drugs Market: Regional Segment Analysis
USA
Europe
Japan
China
India
South East Asia

Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-ICR-HnM-20027

The Players mentioned in our report
Johnson & Johnson
Abbott Laboratories
F. Hoffmann-La Roche
Takeda Pharmaceuticals
Actavis
Akebia Therapeutic
Raptor Pharmaceuticals
Rockwell Medical
AMAG Pharmaceuticals
Sanofi
Reata Pharmaceuticals
Cara Therapeutics
FibroGen

About Us:
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Runwal Platinum,
Ramnagar Colony, Bavdhan,
Pune, Maharashtra, India-411021
www.qurateresearch.com/
IN +919881074592
info@qurateresearch.com

This release was published on openPR.
News-ID: 1173083 • Views: 132
More releasesMore releases

You can edit or delete your press release here: